SeQuent Scientific’s wholly owned subsidiary -- Sequent Research -- has opened its new GLP (Good Laboratory Practices) compliant Analytical Services Centre at Bengaluru. Built with a laboratory space of 10,000 square feet and latest analytical equipment, the new Bengaluru centre will enable company's access to a wider range of therapies including Beta Lactam and Hormones.
The company currently services over a dozen of customers including the leading global companies from its existing centre at Mangalore. This facility is ISO 17025 certified and it has successfully completed its second USFDA inspection in July 2015.
The inauguration of the new facility opens the doors to customers worldwide, to access the Company's best-in class infrastructure coupled with rich scientific knowledge, definitive cost advantage and in-time commitment which adheres to changing regulatory needs and highest quality standards.
Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: